[go: up one dir, main page]

ES2067624T3 - Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal. - Google Patents

Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Info

Publication number
ES2067624T3
ES2067624T3 ES90120880T ES90120880T ES2067624T3 ES 2067624 T3 ES2067624 T3 ES 2067624T3 ES 90120880 T ES90120880 T ES 90120880T ES 90120880 T ES90120880 T ES 90120880T ES 2067624 T3 ES2067624 T3 ES 2067624T3
Authority
ES
Spain
Prior art keywords
nasal administration
preparing
procedure
pharmaceutical composition
liquid pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90120880T
Other languages
English (en)
Inventor
Giancarlo Ceschel
Antonella Maria Segu
Celestino Ronchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ph & T Srl
Original Assignee
Ph & T Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT8922398A external-priority patent/IT8922398A0/it
Priority claimed from IT02094690A external-priority patent/IT1243343B/it
Application filed by Ph & T Srl filed Critical Ph & T Srl
Application granted granted Critical
Publication of ES2067624T3 publication Critical patent/ES2067624T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICION LIQUIDA PARA ADMINISTRACION NASAL DE POLIPEPTIDOS QUE CONTIENE TARTRATO DE AMONIO Y UN AMORTIGUADOR CON AUXILIARES OPCIONALES.
ES90120880T 1989-11-16 1990-10-31 Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal. Expired - Lifetime ES2067624T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8922398A IT8922398A0 (it) 1989-11-16 1989-11-16 Composizioni farmaceutiche ad elevato assorbimento e stabilita', comprendente una calcitonina come sostanza attiva.
IT02094690A IT1243343B (it) 1990-07-16 1990-07-16 Composizione farmaceutica liquida per la somministrazione nasale contenente un polipeptide come sostanza attiva

Publications (1)

Publication Number Publication Date
ES2067624T3 true ES2067624T3 (es) 1995-04-01

Family

ID=26327710

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90120880T Expired - Lifetime ES2067624T3 (es) 1989-11-16 1990-10-31 Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.

Country Status (4)

Country Link
US (1) US5124315A (es)
EP (1) EP0432431B1 (es)
DE (1) DE69001991T2 (es)
ES (1) ES2067624T3 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
IT1265647B1 (it) * 1992-11-18 1996-11-22 Farmin Srl Composizione farmaceutiche topiche per le allergie respiratorie
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
PT708657E (pt) * 1993-06-29 2001-11-30 Ferring Bv Composicoes para administracao nasal de desmopressina
US20030190307A1 (en) * 1996-12-24 2003-10-09 Biogen, Inc. Stable liquid interferon formulations
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6187332B1 (en) * 1999-06-14 2001-02-13 Wisconsin Alumni Research Foundation Acidic buffered nasal spray
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
AT409081B (de) * 2000-02-16 2002-05-27 Gebro Pharma Gmbh Stabile, nasal, oral oder sublingual anwendbare pharmazeutische zubereitung
WO2003097080A1 (en) * 2002-05-15 2003-11-27 Sun Pharmaceutical Industries Limited A stable aqueous composition of a peptide
US7812120B2 (en) * 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744239B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS57130961A (en) * 1981-02-04 1982-08-13 Seiwa Kasei:Kk Polypeptide derived from quaternary trimethylammonium
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
US4466960A (en) * 1983-10-18 1984-08-21 Thompson Medical Co., Inc. Analgesic-diuretic compositions
US4658830A (en) * 1984-08-08 1987-04-21 Survival Technology, Inc. Method and apparatus for initiating reperfusion treatment by an unattended individual undergoing heart attack symptoms
JPS61194034A (ja) * 1985-02-25 1986-08-28 Teijin Ltd 経鼻投与用粉末状組成物
EP0273512B1 (en) * 1986-12-19 1991-02-27 Duphar International Research B.V Stabilised adjuvant suspension comprising dimethyl dioctadecyl ammonium bromide
IT1222395B (it) * 1987-07-30 1990-09-05 Pierrel Spa Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
IT1223132B (it) * 1987-11-13 1990-09-12 Isf Spa Composizione farmaceutica per somministrazione nasale
IL91856A0 (en) * 1988-10-11 1990-06-10 Schiapparelli Salute Spa Pharmaceutical compositions comprising calcitonin for intranasal administration and a spray unit for the administration of the same
US5015626A (en) * 1989-08-02 1991-05-14 Iowa State University Research Foundation, Inc. Porcine somatotropin to improve meat quality of pigs
US5015627A (en) * 1990-07-20 1991-05-14 Smithkline Beecham Corporation Stabilized somatotropin for parenteral administration

Also Published As

Publication number Publication date
DE69001991D1 (de) 1993-07-22
EP0432431B1 (en) 1993-06-16
EP0432431A1 (en) 1991-06-19
DE69001991T2 (de) 1993-09-23
US5124315A (en) 1992-06-23

Similar Documents

Publication Publication Date Title
ES2067624T3 (es) Un procedimiento de preparacion de una composicion farmaceutica liquida para administracion nasal.
IL61375A (en) 4-amino-2-(cyclic amino)-6-chloro-7-alkoxy-quinazoline derivatives,pharmaceutical compositions containing them and the corresponding 2-chlorointermediates therefor
PT84354B (pt) Dispositivo para aplicacao de suspensoes de medicamentos
GB8319513D0 (en) Needleless hypodermic injector
MX9202934A (es) Derivados de carbostirilo y composicion farmaceutica que los contiene.
ES548168A0 (es) Procedimiento para preparar composiciones de uso cosmetico o farmaceutico a base de unas esferulas lipidicas que contienen un polimero de poliamida.
DK166149C (da) Antipsykotiske 1-fluorphenylbutyl-4-(2-pyrimidinyl)-piperazinderivater, farmaceutiske praeparater indeholdende saadanne derivater samt fremgangsmaade til fremstilling af derivaterne
DK128688A (da) Thiazolderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne
MX12478A (es) Benzamidas n-sustituidas, procedimiento para su preparacion y composicion farmaceutica que las incluye
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
MX9205155A (es) Derivados heterociclicos n-substituidos, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DK162054C (da) Cephalosporinsalte, fremgangsmaade til fremstilling deraf samt injicerbare praeparater indeholdende samme
ES2007588B3 (es) Cartucho para inyectar la mezcla de dos componentes liquidos.
MX143965A (es) Mejoras en un procedimiento para la preparacion de una resina epoxidica liquida
IT8722682A0 (it) Compressa per uso oftalmico e rilascio controllato della sostanza attiva.
NO881778L (no) Enkastiner: nye glykopeptider med enkefalinase-hemmende virkning. fremgangsmaate til deres fremstilling og deres anvendelse som farmasoeytiske preparater.
IL52547A (en) N-(1'-allyl-2'-pyrrolidylmethyl)-2,3-dimethoxy-5-sulphamoylbenzamide its optical isomers its n-oxide and pharmaceutically acceptable salts thereof their preparation and pharmaceutical compoistions containing them
DK221288A (da) 2beta-,16beta-diamino-androstaner og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende en saadan forbindelse
FI831367A7 (fi) Pleuromutilliinijohdannaiset, niiden valmistusmenetelmä ja farmaseuttinen käyttö
JO1120B1 (en) N-(1-allye-2-pyrrolidiny-methyl)2methoxy-4-amino-5-methylsulfamoyl benzamide, its method of oreperation and its use as a medicament
DK115289A (da) Tricykliske aminderivater, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende disse
FI905358A7 (fi) Menetelmä (1R,2R)-2-(3-pyridyyli)-2-karbotioamiditetrahydrotiopyran-1-oksidien valmistamiseksi, näin saadut (1R,2R)-2-(3-pyridyyli)-2-karbotioamiditetrahydrotiopyran-1-oksidit ja niitä sisältävät farmaseuttisetvalmisteet
DE3579074D1 (de) Verminderung der toxischen wirkungen von anthrachinon-medikamenten.
IT8822558A0 (it) Soluzione farmaceutica acquosa per uso oftalmico.
MX9202987A (es) Analogos de insulina, formulacion farmaceutica que los contiene y procedimiento para obtener dichos analogos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 432431

Country of ref document: ES